Redwood City, California-based Ambys Medicines, a developer of new medicines patients suffering from chronic liver diseases, has launched with $60 million in Series A financing. The investors were Third Rock Ventures and Takeda.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: